243 related articles for article (PubMed ID: 19154893)
1. Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.
Stiles BM; Servais EL; Lee PC; Port JL; Paul S; Altorki NK
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):13-9. PubMed ID: 19154893
[TBL] [Abstract][Full Text] [Related]
2. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
Bryant AS; Cerfolio RJ
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less.
Port JL; Andrade RS; Levin MA; Korst RJ; Lee PC; Becker DE; Altorki NK
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1611-5. PubMed ID: 16308006
[TBL] [Abstract][Full Text] [Related]
4. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
Shiono S; Abiko M; Sato T
Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
[TBL] [Abstract][Full Text] [Related]
5. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
6. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
Kozower BD; Meyers BF; Reed CE; Jones DR; Decker PA; Putnam JB
Ann Thorac Surg; 2008 Apr; 85(4):1166-9; discussion 1169-70. PubMed ID: 18355490
[TBL] [Abstract][Full Text] [Related]
7. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
10. Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer.
Saisho S; Yasuda K; Maeda A; Yukawa T; Okita R; Hirami Y; Shimizu K; Nakata M
Ann Nucl Med; 2013 Jul; 27(6):515-22. PubMed ID: 23504519
[TBL] [Abstract][Full Text] [Related]
11. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):151-9. PubMed ID: 15999056
[TBL] [Abstract][Full Text] [Related]
12. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
Yoshioka M; Ichiguchi O
Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
14. Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.
Sanli M; Isik AF; Zincirkeser S; Elbek O; Mete A; Tuncozgur B; Elbeyli L
J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1200-5. PubMed ID: 19660381
[TBL] [Abstract][Full Text] [Related]
15. The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit.
Heineman DJ; Ten Berge MG; Daniels JM; Versteegh MI; Marang-van de Mheen PJ; Wouters MW; Schreurs WH
Ann Thorac Surg; 2016 Nov; 102(5):1622-1629. PubMed ID: 27665479
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
17. Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer.
Flieder DB; Port JL; Korst RJ; Christos PJ; Levin MA; Becker DE; Altorki NK
Chest; 2005 Oct; 128(4):2304-8. PubMed ID: 16236888
[TBL] [Abstract][Full Text] [Related]
18. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
Sachs S; Bilfinger TV; Komaroff E; Franceschi D
Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
[TBL] [Abstract][Full Text] [Related]
19. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
Gómez-Caro A; Garcia S; Reguart N; Arguis P; Sanchez M; Gimferrer JM; Marrades R; Lomeña F
Eur J Cardiothorac Surg; 2010 May; 37(5):1168-74. PubMed ID: 20116273
[TBL] [Abstract][Full Text] [Related]
20. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
